Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Result of General Meeting

July 13, 2020
Download  full announcement Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled  in vitro  diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, announces that all resolutions proposed at the

RenalytixAI Announces Partnership with the University of Michigan to Extend KidneyIntelX™ Use to Broad CKD Populations and Data Sharing Agreement with a Top Ten Global Pharmaceutical Company

June 30, 2020
NEW YORK, June 30, 2020 /PRNewswire/ --  Renalytix AI plc  (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs, today announced a partnership with
Displaying 21 - 30 of 128